How AXIS Clinicals helped a global CRO recover a stalled biosimilar study during the height of COVID-19
When the pandemic disrupted clinical research worldwide, one multinational biosimilar study was at risk of falling apart. Enrollment had stalled, timelines slipped, and the sponsor’s commitments hung in the balance.
AXIS Clinicals stepped in as a rescue site and enrolled 50 volunteers in just 90 days—meeting the sponsor’s regulatory deadline while maintaining full data integrity and participant safety.
This case study explores how AXIS combined agility, compliance, and community trust to restore study momentum in the middle of a global shutdown.
See how operational flexibility and collaboration helped preserve trial continuity when it mattered most.
Read the full case study
###
About AXIS Clinicals
AXIS Clinicals is the leading clinical and bioanalytical pharmacology research organization conducting studies in healthy volunteers and targeted populations.
AXIS Clinicals Contact
John Pottier | Senior Vice President, Business Development
+1 (913) 314-6755
j.pottier@axisclinicals.com
axisclinicalsusa.com